Pacira Pharmaceuticals (PCRX) Earnings
|
Expand Research on PCRX
| Next EPS Date | 5/1/24 | EPS Growth Rate | +246.5% |
|---|---|---|---|
| Average EPS % Beat Rate | -55.1% | Revenue Growth Rate | +3.5% |
| Average % Move 1-Wk after EPS | -0.5% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2/29/24 | Q423 | $0.54 | $0.88 | -$0.34 | $181.2M | $180.85M | = |  | | Details | |
| 2/28/23 | Q422 | $0.80 | $0.83 | -$0.03 | $172M | $178.59M | N/A | | | Details | |
8/2/23  |
Q223 | N/A | $0.76 | N/A | N/A | $174.86M | N/A | N/A | N/A | ||
| 11/2/23 | Q323 | $0.72 | $0.78 | -$0.06 | $163.93M | $173.42M | N/A | | | Details | |
| 8/3/22 | Q222 | $0.53 | $0.88 | -$0.35 | $169.4M | $172.22M | N/A | | | Details | |
| 11/3/22 | Q322 | -$0.02 | $0.81 | -$0.83 | $167.5M | $171.24M | N/A | | | Details | |
| 5/1/24 | Q124 | N/A | $0.63 | N/A | N/A | $165.85M | = | N/A | N/A | ||
| 5/4/22 |  |
Q122 | $0.64 | $0.83 | -$0.19 | $158M | $159.34M | N/A | | | Details |
